Legal Opinion
In re Effexor Antitrust Litig.
District Court, D. New Jersey
Decided November 15, 2018No. Civil Action No. 3:11-cv-5661 (PGS)(LHG)PublishedCited by 14 opinions
1Opinion of the Court
SHERIDAN, U.S.D.J.
Presently before the Court is Defendants Wyeth Inc., Wyeth Manufacturing Limited, Wyeth Ireland Pharmaceutical Products (collectively, "Wyeth"), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Industries Limited's (collectively, "Teva") Motion for Judgment on the Pleadings pursuant Federal Rule of Civil Procedure 12(c), regarding End-Payer Plaintiffs' Third Amended Consolidated Complaint. (ECF No. 165).1 This case arises from allegations that two drug companies, Wyeth and Teva, engaged in an anticompetitive scheme that prevented the generic drug of Effexor XR from…
2Cases cited77 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Erie Railroad v. TompkinsSupreme Court of the United States · 1938
- Hanna v. PlumerSupreme Court of the United States · 1965
- DaimlerChrysler Corp. v. CunoSupreme Court of the United States · 2006
72 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2019
- Mayor and City Council v. Actelion Pharmaceuticals Ltd.Court of Appeals for the Fourth Circuit · 2021
- AMATO v. SUBARU OF AMERICA, INC.District Court, D. New Jersey · 2021
- Connecticut v. Aurobindo Pharma USA, Inc.District Court, D. Connecticut · 2025
- HUMANA INC. v. MERCK & COMPANY, INC.District Court, D. New Jersey · 2025
9 more not listed; retrieve them via the Exa API.